1212 related articles for article (PubMed ID: 23478662)
21. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
[TBL] [Abstract][Full Text] [Related]
22. Correlates of Plasma NT-proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial.
Chiu L; Agrawal V; Armstrong D; Brittain E; Collins S; Hemnes AR; Hill JA; Lindenfeld J; Shah SJ; Stevenson LW; Wang TJ; Gupta DK
J Am Heart Assoc; 2024 Apr; 13(7):e031796. PubMed ID: 38533961
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study.
Guazzi M; Vicenzi M; Arena R; Guazzi MD
Circulation; 2011 Jul; 124(2):164-74. PubMed ID: 21709061
[TBL] [Abstract][Full Text] [Related]
24. PDE5 inhibitor sildenafil in the treatment of heart failure: a meta-analysis of randomized controlled trials.
Zhuang XD; Long M; Li F; Hu X; Liao XX; Du ZM
Int J Cardiol; 2014 Apr; 172(3):581-7. PubMed ID: 24534379
[TBL] [Abstract][Full Text] [Related]
25. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
Edelmann F; Wachter R; Schmidt AG; Kraigher-Krainer E; Colantonio C; Kamke W; Duvinage A; Stahrenberg R; Durstewitz K; Löffler M; Düngen HD; Tschöpe C; Herrmann-Lingen C; Halle M; Hasenfuss G; Gelbrich G; Pieske B;
JAMA; 2013 Feb; 309(8):781-91. PubMed ID: 23443441
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial.
Arruda-Olson AM; Mahoney DW; Nehra A; Leckel M; Pellikka PA
JAMA; 2002 Feb; 287(6):719-25. PubMed ID: 11851538
[TBL] [Abstract][Full Text] [Related]
27. Sildenafil improves skeletal muscle oxygenation during exercise in men with intermittent claudication.
Roseguini BT; Hirai DM; Alencar MC; Ramos RP; Silva BM; Wolosker N; Neder JA; Nery LE
Am J Physiol Regul Integr Comp Physiol; 2014 Aug; 307(4):R396-404. PubMed ID: 24944249
[TBL] [Abstract][Full Text] [Related]
28. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
Tapson VF; Torres F; Kermeen F; Keogh AM; Allen RP; Frantz RP; Badesch DB; Frost AE; Shapiro SM; Laliberte K; Sigman J; Arneson C; Galiè N
Chest; 2012 Dec; 142(6):1383-1390. PubMed ID: 22628490
[TBL] [Abstract][Full Text] [Related]
29. Exercise oscillatory ventilation in systolic heart failure: an indicator of impaired hemodynamic response to exercise.
Murphy RM; Shah RV; Malhotra R; Pappagianopoulos PP; Hough SS; Systrom DM; Semigran MJ; Lewis GD
Circulation; 2011 Sep; 124(13):1442-51. PubMed ID: 21875912
[TBL] [Abstract][Full Text] [Related]
30. Sildenafil for chronic obstructive pulmonary disease: a randomized crossover trial.
Lederer DJ; Bartels MN; Schluger NW; Brogan F; Jellen P; Thomashow BM; Kawut SM
COPD; 2012 Jun; 9(3):268-75. PubMed ID: 22360383
[TBL] [Abstract][Full Text] [Related]
31. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
[TBL] [Abstract][Full Text] [Related]
32. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
Mohammed SF; Borlaug BA; McNulty S; Lewis GD; Lin G; Zakeri R; Semigran MJ; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
Circ Heart Fail; 2014 Jul; 7(4):580-9. PubMed ID: 24833648
[TBL] [Abstract][Full Text] [Related]
33. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
[TBL] [Abstract][Full Text] [Related]
34. Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
Margulies KB; Hernandez AF; Redfield MM; Givertz MM; Oliveira GH; Cole R; Mann DL; Whellan DJ; Kiernan MS; Felker GM; McNulty SE; Anstrom KJ; Shah MR; Braunwald E; Cappola TP;
JAMA; 2016 Aug; 316(5):500-8. PubMed ID: 27483064
[TBL] [Abstract][Full Text] [Related]
35. Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial.
Gandhi PU; Gaggin HK; Redfield MM; Chen HH; Stevens SR; Anstrom KJ; Semigran MJ; Liu P; Januzzi JL
JACC Heart Fail; 2016 Nov; 4(11):860-869. PubMed ID: 27744089
[TBL] [Abstract][Full Text] [Related]
36. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial.
Ghofrani HA; Reichenberger F; Kohstall MG; Mrosek EH; Seeger T; Olschewski H; Seeger W; Grimminger F
Ann Intern Med; 2004 Aug; 141(3):169-77. PubMed ID: 15289213
[TBL] [Abstract][Full Text] [Related]
37. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
; Zisman DA; Schwarz M; Anstrom KJ; Collard HR; Flaherty KR; Hunninghake GW
N Engl J Med; 2010 Aug; 363(7):620-8. PubMed ID: 20484178
[TBL] [Abstract][Full Text] [Related]
38. Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS-AF Trial.
Shantsila E; Shahid F; Sun Y; Deeks J; Calvert M; Fisher JP; Kirchhof P; Gill PS; Lip GYH
J Am Heart Assoc; 2020 Sep; 9(18):e016239. PubMed ID: 32909497
[TBL] [Abstract][Full Text] [Related]
39. PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial.
Kim KH; Kim HK; Hwang IC; Cho HJ; Je N; Kwon OM; Choi SJ; Lee SP; Kim YJ; Sohn DW
Am Heart J; 2015 Jun; 169(6):813-822.e3. PubMed ID: 26027619
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
